Some long Covid patients are seeing improvement in persistent symptoms after taking an extended course of the antiviral drug Paxlovid.


KQED health correspondent Lesley McClurg has more on a new UCSF study.

Some long Covid patients are seeing improvement in persistent symptoms after taking an extended course of the antiviral drug Paxlovid. KQED health correspondent Lesley McClurg has more on a new UCSF study.

KQED serves the people of Northern California with a community-supported alternative to commercial media. We provide citizens with the knowledge they need to make informed decisions; convene community dialogue; bring the arts to everyone; and engage audiences to share their stories.

KQED serves the people of Northern California with a community-supported alternative to commercial media. We provide citizens with the knowledge they need to make informed decisions; convene community dialogue; bring the arts to everyone; and engage audiences to share their stories.

Advertisement